sodium valproate
nhfy20250317
Approved small_molecule active
Quick answer
sodium valproate for Epilepsy is a Approved program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Epilepsy
- Phase
- Approved
- Modality
- small_molecule
- Status
- active